Immuno-oncology drug developer Oxis International has agreed to buy Georgetown Translational Pharmaceuticals (GTP) in exchange of 33% of its outstanding shares.
The acquisition will add a class of close-to-market central nervous systems (CNS) products to Oxis, and accelerate the clinical development of cancer and neurologic disease-related treatments.
Go deeper with GlobalData
The merger also includes a $125m upfront payment from Allergan, a company owned by the newly appointed CEO of Oxis. Allergan will also provide potential regulatory and commercial milestones of up to $875m.
Hangzhou Tianmushan Pharmaceutical intends to acquire an AnhuiIn-based pharmaceutical company in a $52.7m deal.
The acquirer plans to raise $26.3m through a private placement of shares to partly fund the acquisition.
Biopharmaceutical company Sinovac Biotech will be bought by Shandong Sinobioway Biomedicine for a cash consideration of $8 a share.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataIn a $2m deal, Zhejiang Jingxin Pharmaceutical will purchase an up to 25% stake in Spes Pharmaceuticals.
